Abstract:Omega-3 fatty acids have been implicated in the aetiology of depressive disorders, though trials supplementing omega-3 to prevent major depressive disorder (MDD) have so far been unsuccessful. Whether this association is causal remains unclear. We used two sample Mendelian randomization (MR) to investigate causality. Genetic variants associated with circulating omega-3 and omega-6 fatty acids in UK Biobank (UKBB, n = 115,078) were selected as exposures. The Psychiatric Genomics Consortium (PGC) genome-wide association studies (GWAS) of MDD ( n = 430,775; cases = 116,209; controls = 314,566) and recurrent depression (rMDD, n = 80,933; cases = 17,451; controls = 62,482), were used as outcomes. Multivariable MR (MVMR) models were used to account for biologically correlated lipids, such as high- and low-density cholesterol and triglycerides, and to explore the relative importance of longer-chain omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) using data from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE, n = 8866). Genetic colocalization analyses were used to explore the presence of a shared underlying causal variant between traits. Genetically predicted total omega-3 fatty acids reduced the odds of MDD (OR IVW 0.96 per standard deviation (SD, i.e. 0.22 mmol/l) (95% CIs 0.93–0.98, p = 0.003)). The largest point estimates were observed for eicosapentaenoic acid (EPA), a long-chain omega-3 fatty acid (OR EPA 0.92; 95% CI 0.88–0.96; p = 0.0002). The effect of omega-3 fatty acids was robust to MVMR models accounting for biologically correlated lipids. 'Leave-one-out' analyses highlighted the FADS gene cluster as a key driver of the effect. Colocalization analyses suggested a shared causal variant using the primary outcome sample, but genomic confounding could not be fully excluded. This study supports a role for omega-3 fatty acids, particularly EPA, in the aetiology of depression, although pleiotropic mechanisms cannot be ruled out. The findings support guidelines highlighting the importance of EPA dose and ratio for MDD and question whether targeted interventions may be superior to universal prevention trials, as modest effect sizes will limit statistical power.

Lowered omega-3 PUFAs are related to major depression, but not to somatization syndrome.

Lowered ω-3 PUFAs are related to major depression, but not to somatization syndrome

Lowered Ω3 Polyunsaturated Fatty Acids in Serum Phospholipids and Cholesteryl Esters of Depressed Patients

Omega 3 polyunsaturated fatty acids and the treatment of depression

Poly unsaturated fatty acids: the missing link between cardiac events and depression?

Fatty Acid Composition in Major Depression: Decreased Ω3 Fractions in Cholesteryl Esters and Increased C20:4ω6C20:5ω3 Ratio in Cholesteryl Esters and Phospholipids

Omega-3 Polyunsaturated Fatty Acids in Depression

Association of dietary saturated fatty acid intake with depression: mediating effects of the dietary inflammation index

Omega-3 PUFAs' efficacy in the therapy of coronary artery disease combined with anxiety or depression: a meta-analysis

Association between plasma polyunsaturated fatty acids and depressive among US adults

Lower Serum Zinc in Major Depression in Relation to Changes in Serum Acute Phase Proteins.

Association between polyunsaturated fatty acids and depression in women with infertility: a cross-sectional study based on the National Health and Nutrition Examination Survey

Efficacy of omega-3 PUFAs in depression: A meta-analysis

Immunological Differences Between Patients with Major Depression and Somatization Syndrome

A Multi-National, Multi-Disciplinary Delphi Consensus Study on Using Omega-3 Polyunsaturated Fatty Acids (N-3 PUFAs) for the Treatment of Major Depressive Disorder

Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: Further evidence that lowered n-PUFAs are related to major depression

Lack of evidence for efficacy of omega‐3 fatty acids in depression

Omega-3 fatty acids for inflamed depression - A match/mismatch study

Relationships between fatty acids and psychophysiological parameters in depressive inpatients under experimentally induced stress

Omega-3 fatty acids and major depression: a Mendelian randomization study

Lowered Zinc and Copper Levels in Drug-Naïve Patients with Major Depression: Effects of Antidepressants, Ketoprofen and Immune Activation.